NCT07294599

Brief Summary

To determine whether the time of day at which daily occlusion therapy is administered-morning, with 2 hours of patching completed within 07:00-10:00, versus evening, with 2 hours completed within 17:00-20:00-affects visual-acuity improvement in the amblyopic eye in children with unilateral amblyopia. Rationale: While occlusion therapy remains the mainstay for treatment of childhood amblyopia, existing trials have focused on patching duration, not on the timing of occlusion. Diurnal or chronobiological factors - such as fluctuations in neuroplasticity, attention, compliance, or visual demand during the day - may influence the efficacy of patching. Understanding whether timing matters could help optimize occlusion therapy, improve outcomes, and reduce treatment burden.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

December 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
Last Updated

August 4, 2026

Status Verified

August 1, 2026

Enrollment Period

8 months

First QC Date

December 8, 2025

Last Update Submit

August 1, 2026

Conditions

Keywords

Morning patchingEvening patchingAmblyopiaClinical trialStrabismusAnisometropia

Outcome Measures

Primary Outcomes (1)

  • Change in best-corrected visual acuity (BCVA) of the amblyopic eye

    Change in best-corrected visual acuity (BCVA) of the amblyopic eye from baseline to month 6, measured using a standardized logMAR (crowded) chart under full refractive correction, by a masked examiner.

    Baseline to Month 6

Secondary Outcomes (3)

  • Adherence percentage reported by caregiver

    Baseline through 6 months

  • Change From Baseline in Stereoacuity at Month 6

    Baseline through month 6

  • At least 2-line improvement

    Baseline and Month 6

Study Arms (2)

Morning patching

EXPERIMENTAL

Participants patched the fellow eye for 2 hours daily within the morning window of 07:00 to 10:00 for 6 months. During patching: child is encouraged to perform near-vision activities (e.g. reading, puzzles, coloring). Duration: 6 months (unless withdrawal criteria met).

Behavioral: eye-patching

Evening patching

EXPERIMENTAL

Participants patched the fellow eye for 2 hours daily within the evening window of 17:00 to 20:00 for 6 months. During patching: same near-vision tasks as Arm 1. Duration: 6 months (unless withdrawal criteria met).

Behavioral: eye-patching

Interventions

eye-patchingBEHAVIORAL

is a non-invasive treatment for Amblyopia ("lazy eye") in children. It involves covering (patching) the stronger, "good" eye so that the weaker (amblyopic) eye is forced to work. This encourages the brain to rely on the amblyopic eye, helping to strengthen its visual pathways.

Also known as: occlusion therapy
Evening patchingMorning patching

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age: 4-8 years.
  • Unilateral amblyopia.
  • Amblyopic-eye BCVA decimal 0.17-0.67 (≈ 6/36-6/9).
  • Fellow-eye BCVA ≥ 0.80 decimal (≈ 6/7.5 or better).
  • Amblyopia type: refractive-dominant or strabismic/mixed.
  • Parent/guardian consent obtained.

You may not qualify if:

  • Bilateral amblyopia.
  • Sensory-deprivation amblyopia (e.g., due to congenital cataract, ptosis, corneal opacity).
  • Ocular surgery within the past 6 months, or planned surgery during study.
  • Likely poor adherence (e.g., due to social, logistic, or family constraints).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Irbid Medical Consultation Center

Irbid, Irbid Governorate, 21163, Jordan

Location

Princess Basma teaching hospital

Irbid, Irbid Governorate, 21163, Jordan

Location

MeSH Terms

Conditions

AmblyopiaStrabismusAnisometropia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve DiseasesRefractive Errors

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Best-corrected visual-acuity assessments were performed by trained examiners who were not involved in patching instruction or adherence assessment and remained masked to treatment assignment throughout follow-up. Allocation was concealed using sequentially numbered, sealed envelopes opened only after eligibility confirmation and completion of the baseline assessment..
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention model: Parallel-group randomized trial. Children with unilateral amblyopia were randomized 1:1 to morning patching, consisting of 2 hours daily within 07:00-10:00, or evening patching, consisting of 2 hours daily within 17:00-20:00. Participants remained in their assigned group for 6 months. Near-vision activities were encouraged during patching. Outcomes were assessed at baseline, Month 3, and Month 6. Randomization was stratified by age group, baseline amblyopic-eye BCVA category, and amblyopia type.⁷
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 19, 2025

Study Start

December 14, 2025

Primary Completion

August 1, 2026

Study Completion

August 1, 2026

Last Updated

August 4, 2026

Record last verified: 2026-08

Locations